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Abstract
BACKGROUND: Migration of colonic lamina propria fibroblasts (CLPF) plays an important role
during mucosal wound healing as well as fibrosis and fistula formation in Crohn's disease (CD).
Recently, we showed that the migratory potential of CD-CLPF was significantly reduced compared to
control CLPF. Fistula-derived CD-CLPF migrated less and fibrosis-CLPF more than CLPF from
inflamed CD mucosa. These changes in migratory behavior were associated with changes in production
of the migration-inducing fibronectin (FN) isoforms ED-A and ED-B. A permanent reduction of the
migratory potential of CLPF was mediated by IFN-gamma and tumor necrosis factor (TNF) modulate
FN isofom expression in CLPF and thereby might regulate CLPF migration. MATERIALS AND
METHODS: Control CLPF were incubated for 72 h with IFN-gamma, TNF, IFN-gamma plus TNF, or
TGF-beta1. Messenger RNA (mRNA) was isolated and expression of FN and isoforms ED-A and ED-B
was quantified by real-time polymerase chain reaction. FN, ED-A, and ED-B were investigated by
Western blotting. FN receptor integrin alpha5beta1 was analyzed by FACS. RESULTS: No difference
was found for the surface display of integrin alpha5beta1 between stimulated and non-stimulated cells.
In TGF-beta1 incubated CLPF mRNA amount of FN and isoforms ED-A and ED-B was slightly
increased. IFN-gamma only decreased FN in CLPF, TNF significantly reduced FN-mRNA by 40%, FN
ED-A mRNA by 25%, and ED-B mRNA by 50%. The TNF-mediated mRNA downregulation resulted
in a decreased protein amount as revealed by Western blotting. CONCLUSION: Cytokines such as
IFN-gamma, TNF, and TGF-beta1 modulate the production of fibronectin isoforms. Our data indicate
that inflammation-induced modulation of FN-isoform production is involved in the alterations of
migratory potential of CLPF isolated from CD mucosa.
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Summary 
BACKGROUND: Migration of colonic lamina propria fibroblasts (CLPFs) plays an 
important role during mucosal wound healing as well as fibrosis and fistulae 
formation in Crohn’s disease (CD). Recently, we demonstrated that the migratory 
potential of CD-CLPFs is significantly reduced as compared to control CLPFs. In 
addition, fistulae-derived CD-CLPF migrated less and fibrosis-CLPF more than CLPF 
from only inflamed CD mucosa. These changes in the migratory behaviour were 
associated with changes in the expression of the migration-inducing fibronectin (FN) 
isoforms ED-A and ED-B. A permanent reduction of the migratory potential of CLPF 
is mediated by IFN-γ and TNF. We therefore investigated whether IFN-γ and TNF  
modulate FN isofom expression in CLPF thereby regulating CLPF migration. 
METHODS: Control-CLPFs were incubated for 72 h with IFN-γ, TNF, IFN-γ plus TNF, 
or TGF-β1. mRNA was isolated and the expression of FN and isoforms ED-A and 
ED-B quantified by real-time PCR. FN-, ED-A- and ED-B-protein expression were 
investigated by Western blotting. The FN receptor integrin α5β1 expression was 
analysed by flow cytometry. 
RESULTS: No difference was found for the expression of integrin α5β1 between 
stimulated control-CLPFs and non-stimulated cells. In CLPFs incubated with TGF-β1 
mRNA expression of FN and the splicing forms ED-A and ED-B was slightly 
increased. IFN-γ only decreased FN-protein expression in CLPFs, TNF significantly 
reduced FN-mRNA expression by 40%, FN ED-A mRNA by 25 % and ED-B mRNA 
by 50 %. Reductions in TNF induced mRNA expression were followed by decreased 
protein expression as revealed by Western blot. 
CONCLUSION: Cytokines such as IFN-γ, TNF, and TGF-β1 modulate the expression 
of fibronectin isoforms. Our data indicate that inflammationinduced modulation of FN-
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isoform expression is involved in the alterations of the migratory potential of CLPFs 
isolated from CD mucosa.  
 
 
Abbreviations: FN: fibronectin, IBD: inflammatory bowel disease, CLPF: colonic 
lamina propria fibroblasts, CD: Cohn’s disease, ED-A: extra domain A, ED-B: extra 
domain B, IIICS: type III connecting segment, EDTA: ethylendiaminetetraacetic acid, 
PBS: phosphate buffered saline, DMEM: Dulbecco´s Modified Eagle’s medium, FCS: 
fetal calf serum, SDS: sodium dodecyl sulfate, GAPDH: glycerinaldehyde-3-
phosphate dehydrogenase  
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Introduction 
Fibronectin (FN) is an extracellular glycoprotein that mediates migration, proliferation, 
differentiation, as well as cell adhesion and plays an important physiological role 
during  embryonic development and tissue injury 1. 
The FNs are disulfide-linked, dimeric matrix proteins with structural type I, II, and III 
domains that bind to cells, collagen, proteoglycans, cell surface receptors, and fibrin 
1, 2. FNs occur in up to 20 different isoforms as a result of alternative splicing of the 
primary transcript in the two homologous type III domains named ED-A and ED-B 
and the one non-homologous repeat termed IIICS 3-7. The ED-A and ED-B segments 
are either entirely included or excluded. The type III repeat may be included, 
excluded, or partially included in FN 8-10. 
The alternatively spliced FN isoforms show distinct functional differences. The 
expression of FN containing ED-A and ED-B domains is significantly increased 
during physiological wound healing and pathological tissue fibrosis 11 as found in 
liver-, kidney-, and lung-fibrosis 12-14, after cardiac transplantation 15 or during 
vascular intimal proliferation 16, and consecutive vascular hypertension 17. The ED-B 
segment, not any other domain, is also a marker of angiogenesis 18. The splicing 
variant ED-A plays a role in the regulation of cell proliferation 19 and differentiation of 
adipocytes and fibroblasts into myofibroblasts 20, 21. In promoting cell spreading and 
cell migration FN ED-A is significantly more potent than FN. Manabe et al. showed 
that the insertion of the ED-A segment is followed by a change in the protein-
conformation of FN so that the RGD binding domain of FN is more accessible for 
integrin α5β1 22.  
Integrins are a family of heterodimeric transmembrane receptors that mediate cell-
extracellular matrix and cell-cell interactions 23. Integrins interact with FN at the III14-
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V region and at the central cell-binding domain (CCBD). CCBD is the major cell-
adhesive domain of FN and contains the Arg-Gly-Asp (RGD) motif 24, which is 
recognized by several integrins including α5β1, αvβ1, αvβ3, αvβ5, αvβ5, αvβ6, 
αIIbβ3, and α8β1 and enhances intestinal epithelial restitution 25. Integrin α5β1 is the 
major FN receptor 26.  
Interactions of integrins with FN as extracellular matrix protein mediate cell adhesion 
and also migration via phosphorylation of kinases and α-actin filaments. Migration of 
human colonic lamina propria fibroblasts (CLPF) plays an important role during  
mucosal wound healing, fibrosis and stricture formation as well as fistulae formation 
in Cohn’s disease (CD). Recently, we demonstrated that in mucosa of patients with 
CD CLPF-migration is significantly reduced compared to control-CLPF 27. Moreover, 
in fistulae the CLPF-migration was further decreased compared to inflamed CD 
mucosa.28 . In addition, we have shown that FN is an essential factor for the induction 
of the migration of CLPF 29. The altered migratory potential in CD CLPF was 
associated with changes in FN isoform expression, while the expression of integrin 
α5β1 was unchanged 30.  
In inflamed mucosa of patients with CD IFN-γ and TNF were found to be upregulated 
significantly. A very similar reduction of the migratory potential as found in CD CLPF 
was caused by a 3 day incubation of control CLPF with IFN-γ and TNF-α 27. 
Therefore, we analyzed whether IFN-γ, TNF and TGF-β1 (as a known inductor of 
tissue fibrosis) modulate FN isoform or integrin expression in CLPF.  
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Materials and methods 
Patients 
Primary human CLPF cultures were obtained from endoscopic biopsies or surgical 
specimens, respectively. CLPF cultures were obtained from intestinal mucosa of 7 
control patients with no intestinal inflammation, who underwent surgery because of 
colon cancer (table 1). All control specimens had no inflammatory infiltrate.  
This study was approved by the Ethics Committee of the University of Regensburg. 
 
Isolation and culture of human CLPF 
Human CLPFs were isolated and cultured as previously described 31. Briefly, the 
mucosa from surgical specimens was cut into 1 mm pieces while the biopsies were 
used directly for the isolation of colonic fibroblasts. Epithelial cells were removed in 
Hank’s Balanced Salt Solution without Ca2+ and Mg2+ (PAA, Cölbe, Germany) with 2 
mM EDTA (Sigma, Deisenhofen, Germany). The remaining tissue was rinsed and -
digested for 30 min at 37°C in phosphate buffered saline (PBS, Gibco, Karlsruhe, 
Germany) containing 1 mg/ml collagenase I (Sigma), 0.3 mg/ml DNase I (Boehringer, 
Mannheim, Germany) and 2 mg/ml hyaluronidase (Sigma). The isolated cells were 
washed with Dulbecco´s Modified Eagle’s medium (DMEM; PAA) containing 20% 
fetal calf serum (FCS; Gibco) and cultured in 25 cm² culture flasks (Costar, 
Bodenheim, Germany) with DMEM containing 10% FCS, penicillin (100 IE/ml), 
streptomycin (100 µg/ml), ciprofloxacin (8 µg/ml), gentamycin (50 µg/ml) and 
amphotericin B (1 µg/ml). Non-adherent cells were removed by subsequent changes 
of medium. The remaining cells were used between passage 3 and 8. 
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Stimulation of human CLPF 
Human CLPFs were splitted when they were confluent. 1.5 –2 Mio cells were seeded 
and cultured for 24 h at 37°C. Medium was removed, the cells were washed twice 
with PBS, and DMEM without FCS and with addition of cytokine was added. CLPFs 
were incubated for 72 h with IFN-γ (10 ng/ml), TNF-α (20 ng/ml), IFN-γ (10 ng/ml) and 
TNF-α (20 ng/ml), or TGF-β1 (20 pg/ml) at 37°C. 
 
FACS analysis 
For FACS analysis CLPFs were detached with trypsin and resuspended in 1% 
BSA/PBS. For each staining 2.5 x 105 cells were placed into 1.5 ml polypropylene 
tubes and 2.5 µl of the antibody solution were added. CLPF were stained for integrin 
subunit α5 with a FITC-conjugated CD49e antibody (DPC Biermann, Germany; 
isotype: mouse IgG2b, Caltag, Burlingame, CA, USA) and for integrin subunit β1 with 
a PE-conjugated CD29 antibody (DPC Biermann; isotype: mouse IgG1, Caltag). 
Incubation was performed in the dark for 30 min on ice. 
Flow cytometry was performed using an Epics XL.MCL (BeckmanCoulter, Krefeld, 
Germany) equipped with an argon ion laser with an excitation power of 15 mW at 488 
nm. The fluorescence of 10 000 cells was collected on a linear scale through right 
angle scatter (side scatter), fluorescence for FITC was collected at 530 nm (FL1), PE 
emission was defined by 580 nm (FL2). 
Analysis gates were set around debris and intact cells on a forward scatter versus 
side scatter dot plot. The fluorescence dot plots were generated using the gated 
data. X-Mean values were used for evaluation. Statistical analysis was performed 
with Student’s t-test. 
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RNA isolation and cDNA synthesis 
For the isolation of total RNA stimulated and unstimulated primary human CLPF-cell 
cultures were washed twice with PBS. CLPFs were scraped off, centrifuged for 5 
min, and resuspended with lysisbuffer from the RNeasy® kit (Qiagen, Hilden, 
Germany). Total RNA was prepared from these CLPFs according to the 
manufacturer’s protocol and stored at –80°C. The isolated RNA was reverse 
transcribed using the Promega Reverse Transcription System (Promega, Madison, 
WI, USA). 
  
Quantitative mRNA analysis by real-time PCR 
The amount of FN- and ED-A- and ED-B-mRNA was quantified by real-time PCR as 
previously described 30. 
The released reporter dye fluorescence during the 40 cycles of amplification was 
monitored using Sequence Detector software (SDS version 2.0, PE Applied 
Biosystems). Reporter dye fluorescence versus PCR cycles was plotted. A threshold 
was set in the exponential phase of the fluorescence curves. The threshold cycle 
numbers (Ct) were calculated.  
Ct values of GAPDH were subtracted from those of FN isoforms: 
dCt = Ct (FN isoforms) – Ct (GAPDH) 
The mean value of the dCt values was calculated. The values of cDNA from 
stimulated CLPFs were subtracted from those of untreated cDNA of the same CLPF: 
  ddCt = dCt (stimulated) – dCt (unstimulated) 
The relative start amount of cDNA was calculated in consideration of the exponential 
amplification: 
  x = 2 -ddCt 
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Western blot 
CLPFs were washed with ice-cold PBS and incubated with 1x RIPA-lysis-buffer with 
proteinase inhibitor (0.05 M Tris, 0.15 M NaCl, 0.25% deoxycholate, 0.05% SDS, 1% 
Triton-X-100, 1 tablet complete proteinase inhibitor mixture (Roche Applied Science, 
Mannheim, Germany) per 10 ml). CLPFs were scraped off and the suspension was 
kept on ice for 30 min and centrifuged (4,000 rpm, 5 min at 4 °C). Protein 
concentration of the supernatant (protein fraction) was determined by BCA assay 
(Sigma). 30 µg of protein were mixed with protein loading buffer containing 2x β-
mercaptoethanol and boiled for 5 min before loading onto a 6 % SDS-polyacrylamide 
gel. After electrophoresis, proteins were transferred onto nitrocellulose membranes 
using the Xcell II Blot Module (Invitrogen, Carlsbad, CA, USA), blocked with 5% milk 
in 0.1% Tween 20-PBS (Sigma) for 30 min and incubated overnight at 4°C with the 
indicated primary antibody. For protein immunoblots specific antibodies to fibronectin 
(1:1000; 35041A, Pharmingen), fibronectin ED-A (1:400; clone IST-9, Abcam), 
fibronectin ED-B (1:200; PhiloMab-2, Philogen) and β-actin (1:5000; Chemicon) were 
used. The membranes were washed six times with 0.1% Tween 20-PBS, incubated 
with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz, CA), 
washed again, and finally incubated with chemiluminescent substrate (ECL Plus; 
Amersham Biosciences, Arlington Heights, IL) for 5 min and then exposed to film 
(Amersham Biosciences). Exposition was quantified by a LAS 1000 (raytest 
Isotopenmessgeräte GmbH, Straubenhardt, Germany). The calculated emissions 
(Advanced Image Data Analyser, Version 3.52, raytest Isotopenmessgeräte GmbH) 
of the FN isoforms were divided by those of the house keeping gene β-actin. The 
corrected emissions of the untreated control was set as 100 percent.. 
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After exposure, the antibody was stripped from the membrane with Re-Blot Plus-
Strong (Chemicon, Hofheim, Germany) for 15 min and the blot was blocked again 
with 5% milk in 0.1% Tween 20-PBS before using it for the next antibody. 
Statistical analysis 
Statistical analysis was performed using paired t-Test. Real time PCR and 
densitometric Western blot data were pictured as boxplots. Differences between 
median values of two data groups were considered significant at a p value < 0.05. 
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Results 
Expression of integrin α5β1 is unchanged by INFγ, TNFα and TGFβ 
To determine whether a reduction of the migratory potential of IFN-γ and TNF 
incubated CLPFs is associated with changes in the expression of integrin α5β1, cell 
surface protein presentation of the integrin subunit α5 and β1 was studied by FACS 
analysis. CLPFs isolated from intestinal mucosa of control persons were treated with 
10 ng/ml IFN-γ, 20 ng/ml TNF, 10 ng/ml IFN-γ and 20 ng/ml TNF and 20 pg/ml TGF-
β1, respectively. These cytokines concentrations had been shown to be effective in 
modulating the migratory potential in previous studies 27. Optimal incubation times 
also had been determined before. Cells were stained with FITC- and PE-conjugated 
antibodies directed against integrin subunit α5 and subunit β1. Non-stimulated 
control cells were cultured only with serum-free media. Figure 1 shows histograms of 
the respective CLPF-cultures. Expression of both integrin subunits could be detected 
on the cell surface of all CLPF-cultures (Fig. 1A). For statistical analysis the mean-X-
values (mean fluorescence intensity) of FITC- and PE-fluorescence of 5 independent 
experiments were analyzed. No significant difference was found between untreated 
and cytokine related CLPFs for both integrin α5 (Fig. 1B) and β1 (Fig. 1C). 
Regulation of mRNA expression of FN isoforms by IFNγ, TNFα and 
TGFβ  
FN- and FN splicing-form mRNA expression was quantified by real-time PCR with 
cDNA from 7 treated and untreated CLPF cultures. The relative start amount of 
cDNA was calculated while the start amount of untreated control CLPFs cDNA was 
set as one.  
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CLPFs incubated with TGF-β expressed significantly more FN- (Fig. 2A) and FN ED-
A (Fig. 2B), as well as FN ED-B (Fig. 2C) –mRNA. Compared to the untreated cells 
FN-mRNA was 1.2-fold increased, FN-ED-A-mRNA was 1.3-fold increased (p < 
0.04), and FN-ED-B-mRNA was 1.2-fold increased (p < 0.05).  
FN-mRNA expression of CLPFs pre-treated with TNF was reduced by 40% (p < 
0.03). FN ED-A mRNA expression was decreased by 25 %, and ED-B mRNA was 50 
% (p < 0.04) reduced.  
Incubation with IFN-γ had no clear effect on FN mRNA-expression in CLPFs.   
When a combination of IFN-γ and TNF was used for the incubation of CLPFs no 
significant difference was observed as compared to TNF alone. The combination was 
followed by a reduction of FN-mRNA expression reduced by 40 % (p < 0.02), FN ED-
A-mRNA expression by 30 % (p < 0.03), and FN ED-B-mRNA expression by 60 % (p 
< 0.00003).   
 
Regulation of protein expression of FN isoforms by IFNγ, TNFα and 
TGFβ  
The expression of FN, FN ED-A, and ED-B protein in CLPFs after stimulation with 
the indicated cytokines was quantified by Western blot. A typical Western blot 
(representative for three separate experiments) is shown in Figure 3. For 
quantification the emission of the Western blot bands was collected by LAS, 
analyzed by AIDA compared to untreated controls for FN (Fig. 4A), FN ED-A (Fig. 
4B), and FN ED-B (Fig. 4C). Total amounts of FN-protein as well as the ED-A and 
ED-B isoforms were decreased by treatment with IFN-γ by 26 %, 30 %, and 31 %, 
respectively,as compared to untreated CLPFs. TNF-stimulation caused a 27 % (FN 
and FN ED-A) and a 23 % decrease (FN ED-B) in protein expression. Both cytokines 
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together reduced the protein amounts of FN, FN ED-A, and FN ED-B by 39 %, 37%, 
and 45 %, respectively, indicating an additive effect of protein expression in contrast 
to mRNA expression.  
In TGF-β1 stimulated CLPFs more FN, FN ED-A and FN ED-B protein was 
detectable compared to untreated cells, however, only the increase for ED-B was 
significant . TGF-β1 stimulation led to an increase of FN, FN ED-A, and FN ED-B 
protein expression of 8 %, 3 %, and 36 %, respectively. 
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Discussion 
Our interest in the regulation of FN splicing and isoform expression was based on a 
line of evidence from previous studies. We had found that CLPF isolated from CD 
patients’ mucosa had a reduced ability to migrate 27. This functional change could be 
induced by incubation of CLPF from normal mucosa with IFNγ and TNFα 27. We 
recently had reported that the change in the migratory behavior of CLPF in CD and 
CD-fistula and CD-strictures was associated with corresponding alterations of the 
expression of FN and the migration- or respectively fibrosis-inducing FN-isoforms 
ED-A and ED-B 30. Consequently we wondered whether the cytokines found to 
influence the migratory potential could have corresponding effects of FN and FN-
isoform expression to further support our hypothesis that this is the mechanisms by 
which the cytokines (at least partially) modulate CLPF migration. 
Indeed we found a very clear reduction of FN, FN-ED-A and ED-B mRNA and protein 
expression induced by incubation with TNF (Fig. 5). However, TNF did not change 
the splicing pattern but reduced the expression of all FN isoform, which also may 
explain a reduction of migration found in inflammation-associated CLPF as we had 
shown the FN is essential for the migration of primary human CLPF 32. 
INFγ only slightly reduced FN mRNA expression; however, protein expression in IFNγ 
treated CLPF was significantly lower as compared to untreated control CLPF further 
supporting the hypothesis that modulation of FN and FN-isoform expression could be 
the cause of changes in the migratory potential of CLPF during mucosal inflammation 
(Fig. 5). 
In inflammatory bowel disease (IBD) an imbalance between pro-inflammatory 
cytokines such as TNF, IFN-γ, interleukins (IL-1β, IL-6, IL-8) 33-35 and anti-
inflammatory cytokines such as IL-4, IL-10, IL-13 36, 37 plays an important role for 
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disease pathophysiology. During inflammation and wound healing TNF and IFN-γ are 
produced by mononuclear cells. In intestinal mucosa of patients with CD and UC 
TNF is secreted by activated macrophages 38-42,43. IFN-γ also has been shown to be 
upregulated in CD 38, 44.  
Interferons have already been reported to be inhibitors of the cell migration 45. IFN-α 
and IFN-γ inhibit the migration of human skin fibroblasts dose-dependently 46. The 
inhibition of migration mediated by interferons has been attributed be an important 
regulator of wound healing. Whether TNF induces or inhibits fibroblast migration 
seems to depend on the type of fibroblast. In skin fibroblasts 47 and in smooth muscle 
cells of the aorta 48 TNF is thought to be a chemoattractant and an activator of 
migration.  
TGF-β1 plays a critical role in the differentiation and activation of myofibroblasts and 
is important during tissue repair and pathogenesis of human fibrotic diseases. 
Myofibroblasts and TGF-β1 are key elements for the development of the traction 
force that is associated with wound contraction and pathological contractures like it’s 
been during development of fibrotic tissue. TGF-β expression is upregulated in 
myofibroblasts at sites of fibrosis in experimental enterocolitis and in CD patients 49. 
TGF-β potently stimulates expression of α-SMA 50 and certainly plays a role in the 
induction of collagen synthesis and matrix deposition 51. It is involved in pathological 
fibrosis and fibrotic diseases of multiple tissues 52. A role of increased TGF-β levels 
for tissue fibrogenesis has been shown for pulmonary fibrosis, liver fibrosis, chronic 
pancreatitis, scleroderma, and renal glomerulosclerosis 52. The importance of TGF-β 
for fibrosis is not only indicated by increased protein expression in fibrotic tissue 
areas but also by the finding that administration of exogenous TGF-β to laboratory 
animals was followed by the development of fibrosis and anti-TGF-β therapies reduce 
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experimentally induced fibrosis 52. TGF-β upregulates fibrillar and nonfibrillar 
collagens, as well as fibronectin and tenascin and the basement membrane proteins 
laminin and entactin 53. TGF-β already has been reported to change the splicing of 
fibronectin 52. 
In summary our in vivo and in vitro studies (Figure 5) show corresponding alterations 
in the migratory potential of CD CLPFs and FN isoform expression. These changes 
on FN expression and the migratory potential are induced by TNFα and IFNγ in 
normal CLPF from healthy mucosa. Our data indicate that mediators of inflammation 
such as TNF or IFN modulate the expression of FN and FN isoform thereby impairing 
the function of CLPF in IBD. Future strategies of prevention of fibrosis or fistula 
formation may be more specifically targeted on the reversion of CLPF function. 
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Table 1: Characteristics of the control patients. Biopsies were taken from different 
locations of colonic mucosa. All cultures were used for real-time PCR. For flow 
cytometry number 94, 181, 186, 191, and 198 were analyzed. Western Blots were 
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Figure 1a: FACS analysis of integrin subunit α5- and β1-protein expression was 
performed in treated and untreated CLPFs from control patients. Cells were 
immunostained with anti-integrin α5 (FL1LOG; light gray histograms), anti-integrin β1 
(FL2LOG, dark gray histograms), and control antibodies (white histogram); Integrin 
α5 and β1 protein expression CLPFs from control patients was unchanged by 
cytokine treatment. 
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Figure 1b: No significant differences of integrin α5β1 expression could be found in 
the CLPF cultures investigated. Flow cytometry analysis was performed with 5 
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Figure 2:  
Quantitative mRNA analysis of FN (A), FN isoforms ED-A (B) and ED-B (C) by real-
time PCR. Control-CLPFs were incubated for 72 h with IFN-γ, TNF, IFN-γ  and TNF, 
or TGF-β1 and total RNA was isolated. The start amount of cDNA isolated from 
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Figure 3:  
Detection of FN, FN ED-A and FN ED-B in CLPFS by Western blotting. 
Cytosolic extracts from treated and untreated CLPFs were analyzed for their FN, FN 
ED-A, and FN ED-B contents. FN as well as FN ED-A and FN ED-B levels were 
upregulated in CLPFS incubated with TGF-β1 and downregulated in CLPFs 
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Figure 4:  
Changes of FN, FN ED-A and FN ED-B protein expression in CLPF cultures. Cells 
were treated for 3 days with IFN-γ, TNF, IFN-γ plus TNF, and TGF-β1 and lysed. 
Unstimulated cells were also lysed and used as control. The quantitative analyses of 
all blots were standardized to β-actin and given as the percentage compared to 
control (100 %). (A) Shows total FN, (B) FN ED-A, and (C) FN ED-B protein 
expression changes. CLPF of 3 different control patients were used in the 
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Figure 5:  
Diagram of IFN-γ- and TNF-, FN-expression, and CLPF-migration in vivo compared 
with the observations in vitro. 
 
 
